Draft:Accreditation Council for Medical Affairs

ACMA Conducted Congressional Briefing on Public Health Imperative of Pharmaceutical Industry Standards for Medical Affairs Professionals

Retrieved on: 
Thursday, March 25, 2021

The growing demands on pharmaceutical Medical Affairs professionals and MSLs as a critical interface between the health care companies and stakeholders including physicians and patients emphasizes the need to standardize and certify core competencies and practices across Medical Affairs teams.

Key Points: 
  • The growing demands on pharmaceutical Medical Affairs professionals and MSLs as a critical interface between the health care companies and stakeholders including physicians and patients emphasizes the need to standardize and certify core competencies and practices across Medical Affairs teams.
  • Board certifying Medical Affairs and MSL professionals is critical to ensuring ethical practices, compliance excellence, and public trust at this crucial time.
  • The ACMA developed the first board certification ever for Medical Affairs professionals and Medical Science Liaisons in 2015, and its Board Certified Medical Affairs Specialist (BCMAS) program is now considered the industry standard in the pharmaceutical industry.
  • The company's flagship Board Certified Medical Affairs Specialist (BCMAS) professional certification program for MSLs and Medical Affairs professionals is the industry standard now in over 70 countries.